MTP

Q: What is the price of Midatech Pharma (MTP) today?

The current price of Midatech Pharma (MTP) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Midatech Pharma (MTP) pay dividends?

Midatech Pharma (MTP) did not pay dividends over the past year.

Midatech Pharma PLC

Price

$ -

return (12m)

0.00%

p/e

0.00

p/bv

0.01

DIVIDEND YIELD

0.00%

MTP price

Midatech Pharma

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MTP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals MTP

review the fundamentals of Midatech Pharma shares

P/E

0.00

Sector: -3.94 Industry: -3.94

P/S (PSR)

0.03

Sector: -4.28 Industry: -4.28

P/BV

0.01

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-6,075.44%

Sector: -67.34% Industry: -67.34%

ROE

-10,615.69%

Sector: -68.37% Industry: -68.37%

ROIC

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

-100.00%

Sector: -41.59% Industry: -41.59%

GROSS MARGIN

100.00%

Sector: 36.47% Industry: 36.47%

OPERATING MARGIN

100.00%

Sector: -40.38% Industry: -40.38%

EV/EBITDA

0.00

Sector: -4.08 Industry: -4.08

EV/EBIT

0.00

Sector: -4.15 Industry: -4.15

PRICE-TO-ASSETS

0.00

Sector: 1.39 Industry: 1.39

BVPS

1,754.69

Sector: 1.80 Industry: 1.80

EPS

-186,271.86

Sector: -2.21 Industry: -2.21

EQUITY-TO-ASSETS RATIO

0.57

Sector: 0.41 Industry: 0.41

LIABILITIES / ASSETS

0.57

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

147.94%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-48.92%

Sector: - Industry: -

Fundamentals MTP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.91	1.65	8.29%	6.56%	$ 149.16 B	11.83%
ABBV	110.89	-60.96	-54.98%	2.96%	$ 403.08 B	5.79%
NVO	10.02	6.09	60.73%	4.34%	$ 191.12 B	37.14%
MRK	33.42	6.50	19.45%	2.75%	$ 298.59 B	13.59%
AZN	26.65	5.84	21.93%	1.79%	$ 276.88 B	17.19%
GILD	17.41	6.85	39.33%	2.47%	$ 160.42 B	30.99%
BMY	16.04	5.81	36.19%	4.37%	$ 116.72 B	15.01%
ZTS	12.68	10.37	81.75%	2.59%	$ 33.52 B	27.79%
REGN	14.94	2.10	14.08%	0.57%	$ 66.09 B	29.65%
HALO	24.20	38.43	158.82%	0.00%	$ 8.44 B	23.13%
AMGN	24.59	20.87	84.87%	2.76%	$ 191.81 B	20.96%
MCK	19.85	-113.34	-570.98%	0.41%	$ 94.53 B	1.18%
HRMY	12.82	2.05	16.00%	0.00%	$ 1.87 B	16.20%
VRTX	26.16	5.86	22.41%	0.00%	$ 113.49 B	35.51%
CAH	31.09	-18.09	-58.20%	0.99%	$ 48.34 B	0.62%
ADMA	11.72	4.96	42.37%	0.00%	$ 1.94 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MTP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Midatech Pharma

Midatech Pharma PLC

Average Investor10 user rating

4.0 (0 people)

United States

12 years

Founded: 2014

2015

Time since IPO - 11 years

18

Employees

Midatech Pharma PLC (United States) is listed on the Nasdaq and has a market capitalization of $57.03 Millions, with shareholders equity totaling $9.51 Billions.

The company employs approximately 18 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Midatech Pharma PLC reported $1.85 Billion in revenue, generating net income of $-1.01 Trillion.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MTP.

Market cap

$ 57.03 Millions

Net worth

$ 9.51 Billions

$ 9,505,367,410.56

Assets

$ 16.61 Billions

$ 16,608,840,885.01

Total Shares Outstanding

5.42 Millions

5,417,000

Average Daily Trading Volume

$ 3.51 Millions

$ 3,514,316.42

Sector

Health Care

Industry

Biotechnology

MTP

MTP revenue and profits

Financial Results MTP

DRAG THE FRAME TO SEE MORE DATA

MTP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

JNJ - Johnson & Johnson

$ 240.87 57,17% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

AZN - AstraZeneca

$ 178.75 23,65% (12M)

P/E

26.65

1.79%

ROE

21.93%

P/BV

5.84

ABBV - AbbVie

$ 227.73 22,97% (12M)

P/E

110.89

2.96%

ROE

-54.98%

P/BV

-60.96

NVO - Novo Nordisk

$ 43.88 --42,37% (12M)

P/E

10.02

4.34%

ROE

60.73%

P/BV

6.09

PFE - Pfizer

$ 26.21 14,30% (12M)

P/E

19.91

6.56%

ROE

8.29%

P/BV

1.65

AMGN - Amgen

$ 355.20 23,91% (12M)

P/E

24.59

2.76%

ROE

84.87%

P/BV

20.87

ARGX - argenx

$ 893.52 54,62% (12M)

P/E

15.95

0.00%

ROE

22.64%

P/BV

3.61

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

JNJ - Johnson & Johnson

$ 240.87 57,17% (12 M)

P/L

27.58

2.18%

ROE

25.92%

P/VP

7.15

AZN - AstraZeneca

$ 178.75 23,65% (12 M)

P/L

26.65

1.79%

ROE

21.93%

P/VP

5.84

ABBV - AbbVie

$ 227.73 22,97% (12 M)

P/L

110.89

2.96%

ROE

-54.98%

P/VP

-60.96

NVO - Novo Nordisk

$ 43.88 --42,37% (12 M)

P/L

10.02

4.34%

ROE

60.73%

P/VP

6.09

PFE - Pfizer

$ 26.21 14,30% (12 M)

P/L

19.91

6.56%

ROE

8.29%

P/VP

1.65

AMGN - Amgen

$ 355.20 23,91% (12 M)

P/L

24.59

2.76%

ROE

84.87%

P/VP

20.87

ARGX - argenx

$ 893.52 54,62% (12 M)

P/L

15.95

0.00%

ROE

22.64%

P/VP

3.61

Frequently Asked Questions

What is the price of Midatech Pharma (MTP) today?

The current price of Midatech Pharma (MTP) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Midatech Pharma (MTP) pay dividends?

Midatech Pharma (MTP) did not pay dividends over the past year.

Is Midatech Pharma (MTP) a good investment?

Midatech Pharma (MTP) is currently trading at $ 0.00 with a P/E ratio of 0.00. This represents a -1% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Midatech Pharma (MTP) stock?

You can buy Midatech Pharma (MTP) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol MTP and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Midatech Pharma (MTP) yield today?

Over the past month, Midatech Pharma (MTP) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Midatech Pharma (MTP) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MTP

Midatech Pharma PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MTP

review the fundamentals of Midatech Pharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Midatech Pharma

Midatech Pharma PLC

United States

12 years

2015

18

PROFIT X PRICE MTP

Financial Results MTP

MTP cash flow

Asset, Revenue and Profit Growth - MTP

MTP balance sheet

BFRA - Biofrontera

JNJ - Johnson & Johnson

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

PFE - Pfizer

AMGN - Amgen

ARGX - argenx

BFRA - Biofrontera

JNJ - Johnson & Johnson

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

PFE - Pfizer

AMGN - Amgen

ARGX - argenx

Frequently Asked Questions